Work

Refining the role of contrast-enhanced mammography in breast cancer screening: insights from the RACER trial

Year: 2024

Type: article

Abstract: The RACER trial by Neeter and colleagues1 is a significant contribution to breast cancer care, marking the first multicentre, open-label, randomized controlled clinical trial on contrast-enhanced mammography (CEM) in a breast cancer screening context. It demonstrates that CEM offers diagnostic accuracy comparable to conventional imaging. However, these findings also raise important questions about the most appropriate clinical application of CEM.

Source: The Lancet Regional Health - Europe

DOI: 10.1016/j.lanepe.2024.101068

Authors: Filippo Pesapane, Enrico Cassano

Institution: European Institute of Oncology

Language: English

Topic: Digital Radiography and Breast Imaging

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $4,000